Balance Sheet: Liabilities and Stockholders’ Equity

The balance sheet provides creditors, investors, and analysts with information on company resources (assets) and its sources of capital (its equity and liabilities). It normally also provides information about the future earnings capacity of a company assets as well as an indication of cash flows that may come from receivables and inventories.

Liabilities represents obligations of a company arising from past events, the settlement of which is expected to result in an outflow of economic benefits from the entity.

Medtronic PLC, consolidated balance sheet: liabilities and stockholders’ equity

US$ in millions

	Apr 28, 2023	Apr 29, 2022	Apr 30, 2021	Apr 24, 2020	Apr 26, 2019	Apr 27, 2018
Current debt obligations	20)	3,742)	11)	2,776)	838)	2,058)
Accounts payable	2,662)	2,276)	2,106)	1,996)	1,953)	1,628)
Accrued compensation	1,949)	2,121)	2,482)	2,099)	2,189)	1,988)
Accrued income taxes	840)	704)	435)	502)	567)	979)
Other accrued expenses	3,580)	3,551)	3,475)	2,993)	2,925)	3,431)
Current liabilities	9,051)	12,394)	8,509)	10,366)	8,472)	10,084)
Long-term debt	24,344)	20,372)	26,378)	22,021)	24,486)	23,699)
Accrued compensation and retirement benefits	1,093)	1,113)	1,557)	1,910)	1,651)	1,425)
Accrued income taxes	2,360)	2,087)	2,251)	2,682)	2,838)	3,051)
Deferred tax liabilities	708)	884)	1,028)	1,174)	1,278)	1,423)
Other liabilities	1,727)	1,410)	1,758)	1,664)	757)	889)
Noncurrent liabilities	30,232)	25,866)	32,972)	29,451)	31,010)	30,487)
Total liabilities	39,283)	38,260)	41,481)	39,817)	39,482)	40,571)
Ordinary shares, par value $0.0001	—)	—)	—)	—)	—)	—)
Additional paid-in capital	24,590)	24,566)	26,319)	26,165)	26,532)	28,127)
Retained earnings	30,392)	30,250)	28,594)	28,132)	26,270)	24,379)
Accumulated other comprehensive loss	(3,499)	(2,265)	(3,485)	(3,560)	(2,711)	(1,786)
Shareholders’ equity	51,483)	52,551)	51,428)	50,737)	50,091)	50,720)
Noncontrolling interests	182)	171)	174)	135)	121)	102)
Total equity	51,665)	52,722)	51,602)	50,872)	50,212)	50,822)
Total liabilities and equity	90,948)	90,982)	93,083)	90,689)	89,694)	91,393)

Based on: 10-K (reporting date: 2023-04-28), 10-K (reporting date: 2022-04-29), 10-K (reporting date: 2021-04-30), 10-K (reporting date: 2020-04-24), 10-K (reporting date: 2019-04-26), 10-K (reporting date: 2018-04-27).

Download chart

Balance sheet item	Description	The company
Current liabilities	Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.	Medtronic PLC current liabilities increased from 2021 to 2022 but then slightly decreased from 2022 to 2023 not reaching 2021 level.
Noncurrent liabilities	Amount of obligation due after one year or beyond the normal operating cycle, if longer.	Medtronic PLC noncurrent liabilities decreased from 2021 to 2022 but then increased from 2022 to 2023 not reaching 2021 level.
Total liabilities	Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.	Medtronic PLC total liabilities decreased from 2021 to 2022 but then slightly increased from 2022 to 2023.
Shareholders’ equity	Total of all stockholders’ equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity stockholders’ equity attributable to the parent excludes the amount of stockholders’ equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.	Medtronic PLC shareholders’ equity increased from 2021 to 2022 but then slightly decreased from 2022 to 2023 not reaching 2021 level.

Medtronic PLC (NYSE:MDT)

Balance Sheet: Liabilities and Stockholders’ Equity